Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Non-cash Items (2019 - 2024)

Fortress Biotech (FBIO) has 5 years of Non-cash Items data on record, last reported at $1.0 million in Q4 2024.

  • For Q4 2024, Non-cash Items changed N/A year-over-year to $1.0 million; the TTM value through Dec 2024 reached $1.0 million, changed N/A, while the annual FY2024 figure was $1.0 million, N/A changed from the prior year.
  • Non-cash Items reached $1.0 million in Q4 2024 per FBIO's latest filing, up from $600000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $400.0 million in Q1 2024 and bottomed at $100000.0 in Q4 2022.
  • Average Non-cash Items over 4 years is $38.5 million, with a median of $600000.0 recorded in 2023.
  • The widest YoY moves for Non-cash Items: up 66566.67% in 2024, down 0.0% in 2024.
  • A 4-year view of Non-cash Items shows it stood at $17.5 million in 2020, then plummeted by 99.43% to $100000.0 in 2022, then surged by 300.0% to $400000.0 in 2023, then skyrocketed by 150.0% to $1.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $1.0 million in Q4 2024, $600000.0 in Q3 2024, and $600000.0 in Q2 2024.